ClinicalTrials.gg
CompletedNCT03584386V-CAMSUpdated Oct 14, 2026Results posted

CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention

An interventional study of Jaspr and Jaspr-at-Home (JAH) in Suicide, sponsored by Evidence-Based Practice Institute, Seattle, WA. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-14.

Primary conditionSuicide(the registry's first term)UnverifiedIs this wrong?Suicide is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Evidence-Based Practice Institute, Seattle, WA · Not applicable, Interventional, and Prevention

How we know

Updated Oct 14, 2026Results postedEnrollment updated+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
103
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This Phase II study is a continuation of the Phase I feasibility study where the investigators fully met and exceeded project aims to design, build, and test the usability and acceptability of an avatar-based system, Jaspr Health ("Jaspr"), for use by suicidal ED patients and medical personnel responsible for their care. Phase II includes a formative phase, during which the investigators will continue conducting usability and acceptability tests of new features, and a summative phase to conduct a clinical trial. SBIR Phase II project aims include: (1) Complete development of Jaspr, including readiness for electronic health record integration; (2) Cultivate and utilize the advisory board so that Jaspr is positioned to meet the needs of diverse healthcare systems and successful conduct of the proposed research; (3) Conduct usability/acceptability tests of new features with target end-users (suicidal patients, including those in the ED, medical providers) and key stakeholders (i.e., administrators); and (4) Conduct a randomized controlled trial (RCT; n=31) of suicidal ED patients comparing Jaspr (n=14) to Care-As-Usual (CAU; n=17). Participants were assessed at baseline while in the ED, and again at 7, 30, and 90 days. The investigators predicted that Jaspr participants will report a significantly greater decrease in suicidal behaviors and ED/hospital admissions, as well as significantly greater increases in use of behavioral coping skills, self-efficacy in coping with distress, and perceived helpfulness of patients' ED experience and satisfaction with the app. This study, however, was paused due to COVID after February, 2020 with a total of 31 participants recruited. The study later resumed at one site; however, because of COVID there were fewer admissions for suicidal behavior to the ED, only 7 participants were enrolled before the study ended recruitment in December, 2020 (RCT; n=7) (Jaspr; n=4) (CAU; n=3). The Telehealth clinical trial was conducted with suicidal outpatients to compare the Jaspr-At-Home companion mobile app (JAH; n=28) and CAU (in addition to crisis safety planning; n=26). Participants were assessed at baseline, 30- and 90-days after the initial session.

02

Conditions studied

  • Suicide

Browse trials for

Keywords

  • Suicidality
  • Collaborative Assessment and Management of Suicidality
  • CAMS
  • Technology
  • Emergency Department
  • Suicide Intervention
  • Suicide Assessment
  • Suicide Prevention
  • Self-Help Device
  • Assistive Technology
03

In context

Suicide Unverified

609 studies on the registry are indexed under Suicide; 163 are open to participants now.

This study's enrollment of 103 is close to the median of 104 across 492 interventional studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

Evidence-Based Practice Institute, Seattle, WA is the lead sponsor of 8 studies on the registry; 1 is open to participants now.

Compared within Suicide, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18 years or older
  • English speaker
  • Have access to a computer or other device (smartphone, tablet) with Internet connection
  • Have access and regularly use an Apple or Android smartphone
  • Have a stable address and housing for the last 30 days

ED RCT Inclusion Criteria:

  • Clinically stable Suicidal Patient* currently admitted to the ED, psychiatric inpatient unit, and medical floors of the participating sites; Suicidal Patients currently receiving outpatient mental health services
  • Hospital medical personnel who treat suicidal patients, hospital administrators, hospital-based peer advocates, and outpatient mental health clinicians and administrators

"Suicidal Patient" is defined as those patients who:

  1. Have explicitly indicated to their treatment provider that they are suicidal and/or are seeking treatment in part because they want to kill themselves or
  2. Have made a suicide attempt in the last six months or
  3. Engaged in non-suicidal self-injurious behaviors with high suicidal ideation (defined as 4 to 5 on a 0-5 point Likert scale) in the past three months.

"Clinically Stable" and not in clear and imminent danger is defined as:

  1. Patients who are oriented to time, place, person and are no longer in acute phase of distress that led to their ED admission (for those in the ED)
  2. For those in outpatient context, patient is not in imminent risk for suicide as deemed by their treatment provider
  3. In all cases, patient is able to follow instructions for mood improvement/distress tolerance protocol to help stabilize their mood; current status is unlikely to worsen as a result of engagement with research staff in study activities as deemed by their treatment provider.

The Site Contact or Coordinators and/or designated medical staff will determine if suicidal patients fit these criteria before referring them to the research team.

Telehealth RCT Inclusion Criteria:

  • Currently receiving outpatient treatment services for suicidality

Exclusion criteria

Exclusion Criteria applicable to all:

  • Acutely psychotic and thus unable to provide
  • Severely agitated (as deemed by physician, nurse, or outpatient therapist)
  • Not fluent in English

Additional Exclusion Criteria for Telehealth RCT only:

  • Prior use of Jaspr or Jaspr-At-Home app
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
103 participants (actual)

Study arms

  • Experimental
    Jaspr (ED RCT) / JAH (Telehealth RCT)

    ED RCT: Phase I (formative): Participants are asked to provide feedback on the Jaspr prototype as it is being refined. Feedback will be gathered via survey measure and interview. Phase II (summative): Patient participants will be randomly assigned to this arm and will be given access to the Jaspr tools as part of their treatment in the ED. Baseline assessment surveys will be administered in the ED, and three follow up assessments after discharge will occur at 7 days, 30 days, and 90 days. Intent to treat sample is defined as completing post-treatment baseline assessment. Telehealth RCT: Outpatient participants will be randomly assigned to receive the Jaspr companion mobile app JAH in addition to their usual outpatient care. Study assessments will be administered remotely at three time points: baseline, 30- and 90-day follow ups. Intent to treat threshold is defined as completing setup of JAH on their personal mobile phone.

    Device: Jaspr · Device: Jaspr-at-Home (JAH)

  • No intervention
    Care As Usual

    ED RCT: Phase II (summative): Patient participants enrolled in the ED RCT will be randomly assigned to this arm so there is an even number of participants in the experimental condition and this condition. Those assigned to this condition will be treated as usual in the ED. Same as the experimental condition, those in the Care As Usual condition will be asked to complete baseline assessment surveys while they are waiting in the ED, and then three subsequent assessments after discharge at 7 days, 30 days, and 90 days. Intent to treat sample is defined as completing post-treatment baseline assessment. Telehealth RCT: Outpatient participants enrolled in the Telehealth RCT will be randomly assigned to CAU in addition to receiving crisis safety planning. Study assessments will be administered remotely at baseline and at 30- and 90-day follow ups. Intent to treat threshold is defined as setting up the control condition crisis stability plan.

Interventions

  • DeviceJaspr

    Jaspr is an integrated software system for use on any device by suicidal patients.

  • DeviceJaspr-at-Home (JAH)

    Jaspr-at-Home is the mobile companion app to Jaspr.

06

What researchers measure

Primary outcomes

  1. Change in Suicide Cognitions Scale (SCS)

    An 18-item psychometrically sound self-report measure, the Suicide Cognitions Scale (SCS) assesses suicidal schemas. Items are scored on a 5-point Likert scale (1=strongly disagree; 5=strongly agree). The score is found by summing the items for a total ranging from 18 to 90 with higher scores indicating worse outcomes. The scale is administered to patient participants at three time-points during the Telehealth RCT to assess change over time.

    Time frame: Baseline, 30 days, and 90 days.

  2. Change in Suicide Related Coping Scale (SRCS)

    17-item, with 5 items scored in reverse, psychometrically-sound self-report measure of coping with suicidal thoughts, urges, and crises that uses a 5-point rating scale (0=strongly disagree; 4=strongly agree); the items are summed, so total range of the scale is 0 to 68, with higher scores indicating higher suicide related coping. It is administered to patient participants at three time-points during Telehealth RCT.

    Time frame: Baseline, 30 days, and 90 days.

  3. Emergency Room Patient Satisfaction Survey

    A seven-item measure frequently used in clinical trials, modified for this study to focus on patient participants' emergency department. The Emergency Room Patient Satisfaction Survey is scored by summing the individual items to produce a range of 1 to 5, with higher scores indicating greater satisfaction. It is administered to patient participants at baseline during Phase II (summative) of the ED RCT.

    Time frame: Baseline.

  4. Change in Safety & Imminent Distress Scale (SIDQ)

    A four-item self-report scale modified for this study to measure emotional distress and self-efficacy in coping with suicidality. For agitation, scores are 1=very calm to 10=very frustrated/agitated. For ability to cope, scores are 1=no ability to cope with thoughts of killing myself to 10=strong ability to cope with thoughts of killing myself. For distress, scores are 1=no distress to 10= the highest distress you have ever felt. Each item is averaged with lower values representing better outcomes for agitation and distress, and higher values representing better outcomes for ability to cope. It is administered to patient participants at each assessment point during Phase II (summative) ED RCT.

    Time frame: Baseline, 7 days, 30 days, and 90 days.

  5. Change in Depression Anxiety and Stress Scale (DASS-21)

    A 21-item self-report measure frequently used in clinical trials, used to measure emotional states of depression, anxiety, and stress. The DASS-21 contains three subscales, depression, anxiety, and stress with seven items each. Each item was rated on a four point scale from 1 (Did not apply to me at all) to 4 (Applied to me very much or most of the time). Subscale totals are obtained by summing the seven item scores and multiplying by two to produce a range of 14 to 56 for each. Higher scores indicate higher severities of depression, anxiety, and stress. It is administered to patient participants at three time-points during the Phase II (summative) Telehealth RCT.

    Time frame: Baseline, 30 days, and 90 days.

  6. Change in Suicide-Related Coping Scale (SRCS)

    This 17-item self-report measure, with 5-items reverse scored, is designed to assess a participant's capacity to cope effectively with their suicidal thoughts. Each item is rated on five point Likert scale from 0 (Strongly Disagree) to 4 (Strongly Agree). These items are summed, resulting in a scale range from 0 to 68, where higher scores indicate higher suicide related coping. It is administered to patient participants at each assessment time-points during Phase II (summative) ED RCT.

    Time frame: Baseline, 7 days, 30 days, and 90 days.

  7. Outpatient Satisfaction Questionnaire

    An eight-item self-report measure to assess patient satisfaction with the care they received, perception of provider, and readiness to maintain safety. Items are rated on a scale of 1 (poor) to 5 (excellent), with higher scores indicating higher levels of satisfaction. It is administered to patient participants at baseline during Phase II (summative) Telehealth RCT.

    Time frame: Baseline

  8. Jaspr-At-Home Patient Satisfaction Survey

    A 12-item self-report measure assessing the usability and satisfaction of the JAH mobile app. Items are averaged, resulting a scale range from 1 (Poor) to 5 (Excellent); higher scores indicate higher satisfaction and usability. It is administered to patient participants at two time-points during Phase II (summative) Telehealth RCT.

    Time frame: 30 days and 90 days.

  9. Jaspr Health Patient Satisfaction Survey

    An 8-item self-report measure assessing the usability and satisfaction of the Jaspr app. Items are averaged, resulting in a scale range from 1(Poor) to 5 (Excellent). Higher scores indicate higher ease of use, helpfulness of the app, feeling cared about by the app, and helpfulness of information provided in the app. It is administered to patient participants at baseline during Phase II (summative) ED RCT.

    Time frame: Baseline.

  10. Change in Nock Intensity Rating Scale

    This 6-item self-report measure is designed to assess a participant's intensity levels related to suicidal thoughts and ability to cope. Each item serves as its own subscale, and are individually scored and rated on a ten point Likert scale from 1 (Not at all) to 10 (Very Strong). For the desire and intention subscales, higher scores indicate worse outcomes. For the resist, safe, cope, and hope subscales, higher scores indicate better outcomes. It is administered to patient participants at each assessment time-points during Phase II (summative) ED and Telehealth RCT.

    Time frame: Baseline, 7 days, 30 days, and 90 days.

Secondary outcomes

  1. Change in Optimism & Hope Scale

    A 14-item self-report measure to assess optimism and hope. Items are scored on a 4-point Likert scale (1=definitely true; 4=definitely false). A total score, 14-56, is obtained by summing scores for each item. The mean score (minimum= 1; maximum= 4) is then calculated by dividing the total score by the number of items in the measure. Lower scores indicate increased optimism and hope. It is administered to patient participants at each assessment time-point during the Telehealth RCT and ED RCT.

    Time frame: Baseline, 7 days, 30 days, and 90 days.

07

Results

Posted Oct 14, 2026

Participant flow

Emergency Department (ED) RCT: We recruited acutely suicidal individuals seeking ED-based psychiatric crisis services from 2 EDs. Patients were randomized to Jaspr or Care-as-usual (CAU). Providers in the EDs referred patients to the study. Telehealth RCT: We recruited outpatients from 3 behavioral health clinics. Outpatients were randomized to Jaspr-at-Home (JAH) or CAU. Providers referred existing patients to the study. Those eligible and consented were assigned to a random condition.

ED RCT (90 days)
Participant flow — ED RCT (90 days)
MilestoneJasprCare As Usual
Started2020
Completed1018
Not completed102
Withdrew: Lost to follow-up91
Withdrew: Withdrawal by subject11
Telehealth RCT (90 days)
Participant flow — Telehealth RCT (90 days)
MilestoneJasprCare As Usual
Started3231
Completed2321
Not completed910
Withdrew: Lost to follow-up55
Withdrew: Withdrawal by subject45

Outcome measures

PrimaryChange in Suicide Cognitions Scale (SCS)

An 18-item psychometrically sound self-report measure, the Suicide Cognitions Scale (SCS) assesses suicidal schemas. Items are scored on a 5-point Likert scale (1=strongly disagree; 5=strongly agree). The score is found by summing the items for a total ranging from 18 to 90 with higher scores indicating worse outcomes. The scale is administered to patient participants at three time-points during the Telehealth RCT to assess change over time.

Time frame:
Baseline, 30 days, and 90 days.
Reported as:
Mean · units on a scale
Change in Suicide Cognitions Scale (SCS)
units on a scaleJaspr-at-HomeCare As Usual
T051.84 ± 13.8147.57 ± 16.27
T3050.61 ± 14.3945.76 ± 17.35
T9042.91 ± 13.6240.86 ± 15.36
PrimaryChange in Suicide Related Coping Scale (SRCS)

17-item, with 5 items scored in reverse, psychometrically-sound self-report measure of coping with suicidal thoughts, urges, and crises that uses a 5-point rating scale (0=strongly disagree; 4=strongly agree); the items are summed, so total range of the scale is 0 to 68, with higher scores indicating higher suicide related coping. It is administered to patient participants at three time-points during Telehealth RCT.

Time frame:
Baseline, 30 days, and 90 days.
Reported as:
Mean · Scores on a scale
Change in Suicide Related Coping Scale (SRCS)
Scores on a scaleJaspr-at-HomeCare As Usual
T042.48 ± 8.6543.31 ± 11.74
T3046.85 ± 10.1445.07 ± 12.56
T9048.79 ± 10.1048.33 ± 11.58
PrimaryEmergency Room Patient Satisfaction Survey

A seven-item measure frequently used in clinical trials, modified for this study to focus on patient participants' emergency department. The Emergency Room Patient Satisfaction Survey is scored by summing the individual items to produce a range of 1 to 5, with higher scores indicating greater satisfaction. It is administered to patient participants at baseline during Phase II (summative) of the ED RCT.

Time frame:
Baseline.
Reported as:
Mean · units on a scale
Emergency Room Patient Satisfaction Survey
units on a scaleJasprCare As Usual
Care from team3.93 ± 1.163.55 ± 1.23
Felt listened to4.07 ± .8843.50 ± 1.23
Readiness to leave3.07 ± 1.482.60 ± 1.42
Likelihood of recommendation4.27 ± 1.163.55 ± 1.23
Visit helpfulness3.60 ± .8283.05 ± 1.23
PrimaryChange in Safety & Imminent Distress Scale (SIDQ)

A four-item self-report scale modified for this study to measure emotional distress and self-efficacy in coping with suicidality. For agitation, scores are 1=very calm to 10=very frustrated/agitated. For ability to cope, scores are 1=no ability to cope with thoughts of killing myself to 10=strong ability to cope with thoughts of killing myself. For distress, scores are 1=no distress to 10= the highest distress you have ever felt. Each item is averaged with lower values representing better outcomes for agitation and distress, and higher values representing better outcomes for ability to cope. It is administered to patient participants at each assessment point during Phase II (summative) ED RCT.

Time frame:
Baseline, 7 days, 30 days, and 90 days.
Reported as:
Mean · units on a scale
Change in Safety & Imminent Distress Scale (SIDQ)
units on a scaleJaspr (ED RCT)Care As Usual
ED0 - Agitation5.67 ± 2.445.80 ± 2.67
ED7 - Agitation3.08 ± 1.713.83 ± 2.36
ED30 - Agitation4.00 ± 2.414.32 ± 2.96
ED90 - Agitation3.22 ± 2.493.94 ± 2.01
ED0 - Ability to Cope4.64 ± 2.215.00 ± 2.47
ED7 - Ability to Cope7.69 ± 2.727.63 ± 2.17
ED30 - Ability to Cope8.71 ± 2.538.26 ± 2.33
ED90 - Ability to Cope8.11 ± 2.807.06 ± 2.82
ED0 - Distress6.87 ± 2.136.85 ± 2.76
ED7 - Distress3.38 ± 1.455.44 ± 2.68
ED30 - Distress3.57 ± 2.034.11 ± 1.99
ED90 - Distress3.13 ± 2.104.28 ± 2.74
PrimaryChange in Depression Anxiety and Stress Scale (DASS-21)

A 21-item self-report measure frequently used in clinical trials, used to measure emotional states of depression, anxiety, and stress. The DASS-21 contains three subscales, depression, anxiety, and stress with seven items each. Each item was rated on a four point scale from 1 (Did not apply to me at all) to 4 (Applied to me very much or most of the time). Subscale totals are obtained by summing the seven item scores and multiplying by two to produce a range of 14 to 56 for each. Higher scores indicate higher severities of depression, anxiety, and stress. It is administered to patient participants at three time-points during the Phase II (summative) Telehealth RCT.

Time frame:
Baseline, 30 days, and 90 days.
Reported as:
Mean · units on a scale
Change in Depression Anxiety and Stress Scale (DASS-21)
units on a scaleJaspr-at-HomeCare As Usual
T0 - Depression42.00 ± 9.1039.59 ± 11.55
T30 - Depression37.92 ± 11.2834.56 ± 12.58
T90 - Depression35.74 ± 9.5033.70 ± 9.92
T0 - Anxiety35.28 ± 9.7929.87 ± 8.35
T30 - Anxiety31.97 ± 9.1030.32 ± 8.58
T90 - Anxiety31.14 ± 8.5728.08 ± 7.89
T0 - Stress40.81 ± 9.4236.27 ± 8.42
T30 - Stress38.23 ± 9.3034.27 ± 9.36
T90 - Stress34.79 ± 7.5633.22 ± 8.39
PrimaryChange in Suicide-Related Coping Scale (SRCS)

This 17-item self-report measure, with 5-items reverse scored, is designed to assess a participant's capacity to cope effectively with their suicidal thoughts. Each item is rated on five point Likert scale from 0 (Strongly Disagree) to 4 (Strongly Agree). These items are summed, resulting in a scale range from 0 to 68, where higher scores indicate higher suicide related coping. It is administered to patient participants at each assessment time-points during Phase II (summative) ED RCT.

Time frame:
Baseline, 7 days, 30 days, and 90 days.
Reported as:
Mean · Scores on a scale
Change in Suicide-Related Coping Scale (SRCS)
Scores on a scaleJasprCare As Usual
ED034.6 ± 5.637.26 ± 12.39
ED749.77 ± 6.5750.00 ± 10.01
ED3048.48 ± 10.5053.73 ± 9.58
ED9049.66 ± 13.2350.29 ± 10.30
PrimaryOutpatient Satisfaction Questionnaire

An eight-item self-report measure to assess patient satisfaction with the care they received, perception of provider, and readiness to maintain safety. Items are rated on a scale of 1 (poor) to 5 (excellent), with higher scores indicating higher levels of satisfaction. It is administered to patient participants at baseline during Phase II (summative) Telehealth RCT.

Time frame:
Baseline
Reported as:
Mean · units on a scale
Outpatient Satisfaction Questionnaire
units on a scaleJaspr-at-HomeCare As Usual
Helpfulness3.68 ± .8204.03 ± .808
Feel listened to4.0 ± .9844.20 ± .847
Care3.88 ± 1.134.27 ± .78
Readiness to keep home safe3.44 ± 1.013.90 ± 1.09
Recommend4.16 ± 1.024.33 ± .922
Overall care4.13 ± .9064.23 ± .817
PrimaryJaspr-At-Home Patient Satisfaction Survey

A 12-item self-report measure assessing the usability and satisfaction of the JAH mobile app. Items are averaged, resulting a scale range from 1 (Poor) to 5 (Excellent); higher scores indicate higher satisfaction and usability. It is administered to patient participants at two time-points during Phase II (summative) Telehealth RCT.

Time frame:
30 days and 90 days.
Reported as:
Mean · units on a scale
Jaspr-At-Home Patient Satisfaction Survey
units on a scaleJaspr-at-Home
Ease3.95 ± .963
JAH Helpfulness3.34 ± 1.20
Care3.50 ± 1.21
DSG Helpfulness3.30 ± 1.15
Recommend3.77 ± 1.16
PrimaryJaspr Health Patient Satisfaction Survey

An 8-item self-report measure assessing the usability and satisfaction of the Jaspr app. Items are averaged, resulting in a scale range from 1(Poor) to 5 (Excellent). Higher scores indicate higher ease of use, helpfulness of the app, feeling cared about by the app, and helpfulness of information provided in the app. It is administered to patient participants at baseline during Phase II (summative) ED RCT.

Time frame:
Baseline.
Reported as:
Mean · units on a scale
Jaspr Health Patient Satisfaction Survey
units on a scaleJaspr
Ease4.47 ± .743
Helpfulness4.00 ± .756
Care3.93 ± .961
Info4.13 ± .834
PrimaryChange in Nock Intensity Rating Scale

This 6-item self-report measure is designed to assess a participant's intensity levels related to suicidal thoughts and ability to cope. Each item serves as its own subscale, and are individually scored and rated on a ten point Likert scale from 1 (Not at all) to 10 (Very Strong). For the desire and intention subscales, higher scores indicate worse outcomes. For the resist, safe, cope, and hope subscales, higher scores indicate better outcomes. It is administered to patient participants at each assessment time-points during Phase II (summative) ED and Telehealth RCT.

Time frame:
Baseline, 7 days, 30 days, and 90 days.
Reported as:
Mean · units on a scale
Change in Nock Intensity Rating Scale
units on a scaleJaspr/Jaspr-at-HomeCare As Usual
T0 - Desire2.72 ± 1.652.46 ± 1.64
T30 - Desire2.81 ± 2.122.43 ± 1.73
T90 - Desire2.43 ± 1.912.35 ± 1.81
T0 - Intention1.56 ± 1.091.36 ± .810
T30 - Intention1.68 ± 1.251.59 ± 1.01
T90 - Intention1.41 ± .871.26 ± .452
T0 - Resist8.75 ± 1.438.27 ± 2.73
T30 - Resist8.96 ± 1.378.21 ± 2.536
T90 - Resist9.13 ± 1.298.81 ± 1.78
T0 - Safe7.71 ± 3.167.76 ± 3.09
T30 - Safe7.96 ± 2.858.00 ± 2.94
T90 - Safe8.39 ± 2.528.57 ± 1.96
T0 - Cope8.23 ± 1.997.93 ± 2.18
T30 - Cope7.96 ± 2.207.96 ± 2.41
T90 - Cope8.74 ± 1.988.86 ± 1.49
T0 - Hope5.03 ± 2.105.44 ± 2.44
T30 - Hope5.19 ± 2.355.20 ± 3.10
T90 - Hope6.04 ± 2.335.95 ± 2.65
ED0 - Desire5.20 ± 2.515.00 ± 2.85
ED7 - Desire2.44 ± 1.133.00 ± 2.90
ED30 - Desire2.17 ± 1.332.07 ± 1.27
ED90 - Desire1.57 ± .9762.56 ± 2.16
ED0 - Intention3.58 ± 2.284.17 ± 3.10
ED7 - Intention1.50 ± .7561.86 ± 1.41
ED30 - Intention1.38 ± .7441.43 ± .852
ED90 - Intention1.43 ± 1.132.0 ± 1.56
ED0 - Resist7.29 ± 2.1286.63 ± 3.22
ED7 - Resist8.92 ± 1.857.63 ± 3.10
ED30 - Resist8.79 ± 2.368.47 ± 2.95
ED90 - Resist7.67 ± 3.128.35 ± 2.42
ED0 - Safe7.29 ± 2.897.21 ± 3.38
ED7 - Safe9.38 ± 1.197.95 ± 2.48
ED30 - Safe8.64 ± 2.538.74 ± 2.20
ED90 - Safe9.67 ± .7078.06 ± 2.60
ED0 - Cope6.17 ± 2.216.70 ± 2.86
ED7 - Cope8.92 ± 1.758.89 ± 1.60
ED30 - Cope8.57 ± 2.148.26 ± 2.77
ED90 - Cope8.38 ± 2.457.94 ± 1.98
ED0 - Hope4.42 ± 2.683.53 ± 1.66
ED7 - Hope7.15 ± 1.686.53 ± 2.67
ED30 - Hope7.50 ± 2.477.47 ± 2.31
ED90 - Hope7.22 ± 2.116.33 ± 3.0
SecondaryChange in Optimism & Hope Scale

A 14-item self-report measure to assess optimism and hope. Items are scored on a 4-point Likert scale (1=definitely true; 4=definitely false). A total score, 14-56, is obtained by summing scores for each item. The mean score (minimum= 1; maximum= 4) is then calculated by dividing the total score by the number of items in the measure. Lower scores indicate increased optimism and hope. It is administered to patient participants at each assessment time-point during the Telehealth RCT and ED RCT.

Time frame:
Baseline, 7 days, 30 days, and 90 days.
Reported as:
Mean · units on a scale
Change in Optimism & Hope Scale
units on a scaleJaspr (ED RCT) / JAH (Telehealth RCT)Care As Usual
T02.55 ± .412.50 ± .33
T302.55 ± .392.38 ± .38
T902.45 ± .382.26 ± .35
ED02.84 ± .542.90 ± .47
ED72.41 ± .292.45 ± .49
ED302.35 ± .542.36 ± .50
ED902.30 ± .672.45 ± .54

Adverse events

Collected over Adverse event data was collected over the duration of the study (90 days each for the ED RCT and the Telehealth RCT). Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Jaspr0/52 (0%)0/52 (0%)17/52 (32.7%)
Care As Usual0/50 (0%)0/50 (0%)17/50 (34%)
Most frequent other events
Most frequent other events
EventJasprCare As Usual
Unauthorized Disclosure of Participant Names to Other ParticipantsSocial circumstances16/5215/50
Crisis Hotline OfferedPsychiatric disorders1/523/50

Baseline characteristics

The periods listed in the Participant Flow reflect the total numbers started, completed, and not completed for each RCT, the ED RCT and the Telehealth RCT. The overall number of baseline participants combines the ED RCT and Telehealth RCT totals and differs from the enrollment number because of missing data and 1 participant was lost to follow-up before baseline data was collected

Age, Categorical
Age, Categorical(Participants)JasprCare As UsualTotal
ED RCT — <=18 years011
ED RCT — Between 18 and 65 years111425
ED RCT — >=65 years022
Age, Continuous
Age, Continuous(years)JasprCare As UsualTotal
ED RCT26.73 ± 10.29739.06 ± 16.9234.21 ± 15.70
Sex: Female, Male
Sex: Female, Male(Participants)JasprCare As UsualTotal
ED RCT — Female61117
ED RCT — Male5611
Telehealth RCT — Female272754
Telehealth RCT — Male549
Race (NIH/OMB)
Race (NIH/OMB)(Participants)JasprCare As UsualTotal
ED RCT — American Indian or Alaska Native000
ED RCT — Asian000
ED RCT — Native Hawaiian or Other Pacific Islander000
ED RCT — Black or African American011
ED RCT — White91524
ED RCT — More than one race213
ED RCT — Unknown or Not Reported000
Telehealth RCT — American Indian or Alaska Native000
Telehealth RCT — Asian022
Telehealth RCT — Native Hawaiian or Other Pacific Islander000
Telehealth RCT — Black or African American000
Telehealth RCT — White292554
Telehealth RCT — More than one race347
Telehealth RCT — Unknown or Not Reported000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)JasprCare As UsualTotal
ED RCT — Hispanic or Latino101
ED RCT — Not Hispanic or Latino101727
ED RCT — Unknown or Not Reported000
Telehealth RCT — Hispanic or Latino336
Telehealth RCT — Not Hispanic or Latino292857
Telehealth RCT — Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(Count of Participants)JasprCare As UsualTotal
United States434891
08

Study locations

1 site
  • Evidence-Based Practice Institute
    Seattle, Washington 98126, United States
09

References and documents

Publications

  • Dimeff LA, Jobes DA, Koerner K, Kako N, Jerome T, Kelley-Brimer A, Boudreaux ED, Beadnell B, Goering P, Witterholt S, Melin G, Samike V, Schak KM. Using a Tablet-Based App to Deliver Evidence-Based Practices for Suicidal Patients in the Emergency Department: Pilot Randomized Controlled Trial. JMIR Ment Health. 2021 Mar 1;8(3):e23022. doi: 10.2196/23022. PubMed 33646129 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — Requests for use of data will be considered on a case-by-case basis. Interested researchers may send data requests to research@ebpi.org

10

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2018 to primary completion in Mar 2021, 29 months.

Results were first posted in Oct 2026, 5 years 6 months after primary completion.

Of 321 interventional studies with no phase under Suicide, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 53. This study's 29 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 11, 2018
First posted
Jul 12, 2018
StartActual
Oct 1, 2018
Primary completionActual
Mar 31, 2021
CompletionActual
Mar 31, 2021
Results first posted
Oct 14, 2026
Last update
Oct 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Results
Results posted
posted Oct 14, 2026
Enrollment
357→103
Oct 14, 2026
Interventions
Added Device: Jaspr·Device: Jaspr-at-Home (JAH); removed Device: V-CAMS (aka Jaspr). Arms added: Jaspr (ED RCT) / JAH (Telehealth RCT); arms removed: V-CAMS (aka Jaspr)
Oct 14, 2026
Primary outcomes
3 edited, 1 time frame changed, 4 added, 5 removed, 3 description edited
What changed in the outcomes
  • EditedChange in the Depression Anxiety and Stress Scale (DASS-21)Time frame: Baseline, 30 days, and 90 days.
  • EditedChange in Outpatient Satisfaction QuestionnaireTime frame: Baseline, 30 days, and 90 days. → Baseline
  • EditedChange in Jaspr-At-Home Patient Satisfaction SurveyTime frame: Baseline, 30 days, and 90 days. → 30 days and 90 days.
  • AddedChange in Suicide Related Coping Scale (SRCS)Time frame: Baseline, 30 days, and 90 days.
  • AddedEmergency Room Patient Satisfaction SurveyTime frame: Baseline.
  • AddedJaspr Health Patient Satisfaction SurveyTime frame: Baseline.
  • AddedChange in Nock Intensity Rating ScaleTime frame: Baseline, 7 days, 30 days, and 90 days.
  • RemovedChange in Patient Health Questionnaire-9 (PHQ-9)Time frame: Baseline, 7 days, 30 days, and 90 days.
  • RemovedChange in Coping Skills UseTime frame: Baseline, 7 days, 30 days, and 90 days.
  • RemovedChange in Client Satisfaction Questionnaire (CSQ)Time frame: Baseline, 7 days, 30 days, and 90 days.
  • RemovedChange in Suicide Attempt and Self-Injury QuestionsTime frame: Baseline, 30 days, and 90 days.
  • RemovedChange in the Suicide Behaviors Questionnaire - Revised (SBQ-R)Time frame: Baseline, 30 days, and 90 days.
  • Time frameChange in Suicide Cognitions Scale (SCS)Baseline, 7 days, 30 days, and 90 days. → Baseline, 30 days, and 90 days.
  • DescriptionChange in Safety & Imminent Distress Scale (SIDQ): how it is measured was reworded
  • DescriptionChange in Suicide Cognitions Scale (SCS): how it is measured was reworded
  • DescriptionChange in Suicide-Related Coping Scale (SRCS): how it is measured was reworded
Oct 14, 2026
Secondary outcomes
3 removed, 1 description edited
What changed in the outcomes
  • RemovedUsability Satisfaction and Acceptability Questionnaire (USAQ)Time frame: Up to one day
  • RemovedChange in Provider Ratings QuestionnaireTime frame: Baseline, 7 days, 30 days, and 90 days.
  • DescriptionChange in Optimism & Hope Scale: how it is measured was reworded
  • Removedother outcomeSemi-Structured InterviewTime frame: Up to one day
Oct 14, 2026
Sponsor
Collaborators added: Allina Health System; collaborators removed: Allina Health
Oct 14, 2026
Show all 1 update
  1. Oct 14, 2026
    Results posted
    Enrollment 357→103
    Primary outcomes 3 edited, 1 time frame changed, 4 added, 5 removed, 3 description edited
    What changed in the outcomes
    • EditedChange in the Depression Anxiety and Stress Scale (DASS-21)Time frame: Baseline, 30 days, and 90 days.
    • EditedChange in Outpatient Satisfaction QuestionnaireTime frame: Baseline, 30 days, and 90 days. → Baseline
    • EditedChange in Jaspr-At-Home Patient Satisfaction SurveyTime frame: Baseline, 30 days, and 90 days. → 30 days and 90 days.
    • AddedChange in Suicide Related Coping Scale (SRCS)Time frame: Baseline, 30 days, and 90 days.
    • AddedEmergency Room Patient Satisfaction SurveyTime frame: Baseline.
    • AddedJaspr Health Patient Satisfaction SurveyTime frame: Baseline.
    • AddedChange in Nock Intensity Rating ScaleTime frame: Baseline, 7 days, 30 days, and 90 days.
    • RemovedChange in Patient Health Questionnaire-9 (PHQ-9)Time frame: Baseline, 7 days, 30 days, and 90 days.
    • RemovedChange in Coping Skills UseTime frame: Baseline, 7 days, 30 days, and 90 days.
    • RemovedChange in Client Satisfaction Questionnaire (CSQ)Time frame: Baseline, 7 days, 30 days, and 90 days.
    • RemovedChange in Suicide Attempt and Self-Injury QuestionsTime frame: Baseline, 30 days, and 90 days.
    • RemovedChange in the Suicide Behaviors Questionnaire - Revised (SBQ-R)Time frame: Baseline, 30 days, and 90 days.
    • Time frameChange in Suicide Cognitions Scale (SCS)Baseline, 7 days, 30 days, and 90 days. → Baseline, 30 days, and 90 days.
    • DescriptionChange in Safety & Imminent Distress Scale (SIDQ): how it is measured was reworded
    • DescriptionChange in Suicide Cognitions Scale (SCS): how it is measured was reworded
    • DescriptionChange in Suicide-Related Coping Scale (SRCS): how it is measured was reworded
    Secondary outcomes 3 removed, 1 description edited
    What changed in the outcomes
    • RemovedUsability Satisfaction and Acceptability Questionnaire (USAQ)Time frame: Up to one day
    • RemovedChange in Provider Ratings QuestionnaireTime frame: Baseline, 7 days, 30 days, and 90 days.
    • DescriptionChange in Optimism & Hope Scale: how it is measured was reworded
    • Removedother outcomeSemi-Structured InterviewTime frame: Up to one day
    Interventions Added Device: Jaspr·Device: Jaspr-at-Home (JAH); removed Device: V-CAMS (aka Jaspr). Arms added: Jaspr (ED RCT) / JAH (Telehealth RCT); arms removed: V-CAMS (aka Jaspr)
    Sponsor Collaborators added: Allina Health System; collaborators removed: Allina Health
    + 4 other changes: verification date, description, registry notes and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT03584386
Lead sponsor
Evidence-Based Practice Institute, Seattle, WA
Collaborators
Mayo Clinic, Allina Health System, Wake Forest University Health Sciences, Harborview Injury Prevention and Research Center, The Catholic University of America
Responsible party
Sponsor
First posted
Jul 12, 2018
Start date
Oct 1, 2018
Primary completion
Mar 31, 2021
Completion
Mar 31, 2021
Results posted
Oct 14, 2026
Last update
Oct 14, 2026

Study contacts

Linda Dimeff, PhD
principal investigator · Evidence-Based Practice Institute
David A Jobes, PhD
principal investigator · The Catholic University of America

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion